Evidence map›Paper›PMID 40399985›Full record

ReviewJournal of ovarian research2025

Gut microbiota and ovarian diseases: a new therapeutic perspective.

Shan Ju, Zhen Yang Kang, Li Ya Yang, Yong Jun Xia, Yi Ming Guo, Sui Li, Hongli Yan, Ming Kang Qi, Hui Ping Wang, Lian Zhong

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of ovarian research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shan Ju *School of Health Science and Engineering, Shanghai Engineering Research Center of Food Microbiology, University of Shanghai for Science and Technology, Shanghai, 200093, PR China.
Zhen Yang Kang *Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.
Li Ya YangNHC Key Laboratory of Reproductive Health Engineering Technology Research (NRIFP), National Research Institute for Family Planning, Beijing, 100081, China.
Yong Jun XiaSchool of Health Science and Engineering, Shanghai Engineering Research Center of Food Microbiology, University of Shanghai for Science and Technology, Shanghai, 200093, PR China.
Yi Ming GuoGraduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.
Sui LiSchool of Health Science and Engineering, Shanghai Engineering Research Center of Food Microbiology, University of Shanghai for Science and Technology, Shanghai, 200093, PR China.
Hongli YanChanghai hospital, the Navy medical university, 200433, shanghai, China.
Ming Kang QiGraduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.
Hui Ping Wang *Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China. wanghuiping@nrifp.org.cn.
Lian Zhong *School of Health Science and Engineering, Shanghai Engineering Research Center of Food Microbiology, University of Shanghai for Science and Technology, Shanghai, 200093, PR China. ailianzhong1@126.com.

Funding

the national science fund for distinguished young scholars 32025029the non-profit central research institute fund of national research institute for family planning 2023GJM08；2023GJZD01the Shanghai Education Committee Scientific Research Innovation Projects 2101070007800120the Shanghai engineering research center of food microbiology program 19DZ2281100
6 · The paper itself

Abstract

The gut microbiota is a complex community of microorganisms that inhabit the human gastrointestinal tract, helping to maintain the ecological balance of the body's internal and external environments. Disruptions in the composition and diversity of gut microbiota, as well as changes in their metabolic functions, can link to the development and severity of conditions such as premature ovarian insufficiency, polycystic ovary syndrome, and ovarian tumors. This article thoroughly reviews recent research on the connection between gut microbiota and ovarian diseases, providing fresh perspectives on their prevention, pathogenesis, and treatment.

Indexed as

Gastrointestinal MicrobiomeOvarian DiseasesAnimalsFemaleHumansOvarian NeoplasmsPolycystic Ovary SyndromeGut microbiotaOvarian tumorsPolycystic ovary syndromePremature ovarian insufficiency

Identifiers

PMID40399985
PMCPMC12093725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.